富美实1.14亿美元出售研发总部地产,售后回租保障Stine中心持续运营

大农化网报道:富美实(FMC)公司近日宣布,已就出售其位于特拉华州纽瓦克的地产签署框架协议,交易总价约为1.14亿美元。此次出售的物业为FMC全球研发总部所在地——Stine研究中心。   交易完成后,FMC计划通过单独的租赁协议…

AI Framework Surfaces New CAR T Target with Multi‑Cancer Potential

A new study in Cell describes an AI‑enabled strategy that could accelerate the search for next‑generation CAR T cell targets—an enduring bottleneck in expanding the therapy beyond blood cancers. The work, titled “AI‑driven discovery of GPNMB CAR T cells as a multi‑cancer therapy,” was led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Penn’s Abramson Cancer Center , with collaborators at the Icahn School of Medicine at Mount Sinai and RWTH Aachen University .

FAO Investment Centre: Turning Potential Into Progress

June 2026, Rome: Agrifood systems are being tested like never before, threatening global food security, livelihoods, pea…

Norway and FAO Scale Up Forest Monitoring For Climate Action

June 2026, London: The Food and Agriculture Organization of the United Nations (FAO) today announced a new investment fr…

Goterra administrator seeks buyer as founder warns of insect ag sector ‘contagion’

The administrator for Australian insect waste management firm Goterra says it is “continuing to trade the business at a …

India’s ‘Smart Seeds’ Use Biopolymer Coating to Survive Drought

India’s oilseed scientists say they’ve found a low-tech way to help farmers beat erratic weather: coat the seed itself.

中国水稻杀虫剂:大田试验驱动的产品创新与案例分享

田间试验数据失真的根源,往往藏在最容易被忽视的设计环节里
一个新化合物的田间试验结果显示效果良好,企业据此推进登记、定价、上市——但市场反馈却频频出现偏差:有些区域效果不及预期,有些客户反馈与试验结论不符。问题往往不在产品本身,而在试验设计阶段就已经埋下了系统性偏差。

Recordati secures ex-U.S. rights to Ionis’ Alexander disease therapy

Why it matters: Alexander disease (AxD) is a rare, progressive and often fatal neurological disorder caused by mutations in the GFAP gene. The disease affects astrocytes, critical support cells in the brain, leading to progressive loss of neurological function, including mobility, independence, swallowing and breathing. Symptoms vary by age of onset, and patients often die within 14–25 years after symptoms begin. There are currently no approved disease-modifying therapies for AxD.

Antibiotics Trigger Protein Sharing Among Bacteria, Aiding Persister Cells

Source: AlexRatha/Getty ImagesNew research headed by scientists at Baylor College of Medicine suggests that when bacteria are under antibiotic attack, it is not “every man for himself.” The team developed a genetic system in Escherichia coli to track how the cells transferred proteins between them. The results indicated that bacterial populations work as a team to survive antibiotics, pooling their resources and helping quiescent or dormant cells survive. Using different techniques, including high-resolution imaging, the team found that antibiotic treatment induced the transfer of proteins between different E. coli strains, and between E. coli and other species of bacteria.

Singapore Ranks Amongst World’s Ten Most Food-resilient Nations, Says New Index

June 2026, Singapore: Singapore has ranked among the world’s ten most resilient food systems in a latest study by …